Floatz logo

Olea europaea oil

Dysbiosis

Mucosa Innovations, S.L.mixtureN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Dysbiosis cohort.

Asset / SponsorPhaseRating
Inulin
Emory University
Phase 4BB
VITAMIN D
Emory University
Phase 4BB
Trimethylglycine
Mucosa Innovations, S.L.
N/AD
ALLERGENIC EXTRACT- APPLE MALUS SP
University of Guelph
N/AD
Xylitol
Mucosa Innovations, S.L.
N/AD

Same molecule, other indications

Olea europaea oil is also rated in:

radiodermatitisDormant
BB
Indicative ·
69 / 100
View asset →
inflammatory diseaseDormant
D
Indicative ·
30 / 100
View asset →
morbid obesityDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →